This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
ASCO® Gastrointestinal Cancers Symposium 2023
Presentations
Tucatinib | Colorectal Cancer | Abstract #198
HER2 testing in colorectal cancer: Concordance analysis between breast and gastric scoring algorithms from the MOUNTAINEER trial
Tucatinib | Colorectal Cancer | Abstract #TPS261
MOUNTAINEER-03: Phase 3 study of tucatinib, trastuzumab, and mFOLFOX6 as first-line treatment in HER2+ metastatic colorectal cancer (trial in progress)
Colorectal Cancer | Abstract #53
Burden of Illness in Metastatic Colorectal Cancer
SEA-CD40 | Pancreatic Ductal Adenocarcinoma | Abstract #708
Updated Results of a Phase 1 Study of SEA-CD40, Gemcitabine, Nab-Paclitaxel, and Pembrolizumab in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (SGNS40-001)